Xiamen Amoytop Biotech Statistics
Total Valuation
SHA:688278 has a market cap or net worth of CNY 31.87 billion. The enterprise value is 31.22 billion.
Market Cap | 31.87B |
Enterprise Value | 31.22B |
Important Dates
The last earnings date was Friday, March 28, 2025.
Earnings Date | Mar 28, 2025 |
Ex-Dividend Date | May 23, 2024 |
Share Statistics
SHA:688278 has 406.80 million shares outstanding. The number of shares has increased by 0.56% in one year.
Current Share Class | n/a |
Shares Outstanding | 406.80M |
Shares Change (YoY) | +0.56% |
Shares Change (QoQ) | -0.60% |
Owned by Insiders (%) | 48.01% |
Owned by Institutions (%) | 10.34% |
Float | 126.10M |
Valuation Ratios
The trailing PE ratio is 38.60 and the forward PE ratio is 29.79. SHA:688278's PEG ratio is 0.90.
PE Ratio | 38.60 |
Forward PE | 29.79 |
PS Ratio | 11.34 |
PB Ratio | 12.48 |
P/TBV Ratio | 13.38 |
P/FCF Ratio | 177.78 |
P/OCF Ratio | n/a |
PEG Ratio | 0.90 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 29.92, with an EV/FCF ratio of 174.14.
EV / Earnings | 37.72 |
EV / Sales | 11.08 |
EV / EBITDA | 29.92 |
EV / EBIT | 32.28 |
EV / FCF | 174.14 |
Financial Position
The company has a current ratio of 4.34, with a Debt / Equity ratio of 0.00.
Current Ratio | 4.34 |
Quick Ratio | 3.55 |
Debt / Equity | 0.00 |
Debt / EBITDA | 0.01 |
Debt / FCF | 0.05 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 37.37% and return on invested capital (ROIC) is 27.19%.
Return on Equity (ROE) | 37.37% |
Return on Assets (ROA) | 22.36% |
Return on Invested Capital (ROIC) | 27.19% |
Return on Capital Employed (ROCE) | 36.78% |
Revenue Per Employee | 1.44M |
Profits Per Employee | 422,246 |
Employee Count | 1,960 |
Asset Turnover | 1.04 |
Inventory Turnover | 0.81 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.86% in the last 52 weeks. The beta is 0.22, so SHA:688278's price volatility has been lower than the market average.
Beta (5Y) | 0.22 |
52-Week Price Change | +24.86% |
50-Day Moving Average | 80.38 |
200-Day Moving Average | 68.31 |
Relative Strength Index (RSI) | 45.32 |
Average Volume (20 Days) | 3,950,221 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688278 had revenue of CNY 2.82 billion and earned 827.60 million in profits. Earnings per share was 2.03.
Revenue | 2.82B |
Gross Profit | 2.63B |
Operating Income | 967.17M |
Pretax Income | 931.03M |
Net Income | 827.60M |
EBITDA | 1.04B |
EBIT | 967.17M |
Earnings Per Share (EPS) | 2.03 |
Balance Sheet
The company has 661.79 million in cash and 8.94 million in debt, giving a net cash position of 652.85 million or 1.60 per share.
Cash & Cash Equivalents | 661.79M |
Total Debt | 8.94M |
Net Cash | 652.85M |
Net Cash Per Share | 1.60 |
Equity (Book Value) | 2.55B |
Book Value Per Share | 6.28 |
Working Capital | 1.41B |
Cash Flow
In the last 12 months, operating cash flow was 430.63 million and capital expenditures -251.35 million, giving a free cash flow of 179.28 million.
Operating Cash Flow | 430.63M |
Capital Expenditures | -251.35M |
Free Cash Flow | 179.28M |
FCF Per Share | 0.44 |
Margins
Gross margin is 93.49%, with operating and profit margins of 34.33% and 29.38%.
Gross Margin | 93.49% |
Operating Margin | 34.33% |
Pretax Margin | 33.05% |
Profit Margin | 29.38% |
EBITDA Margin | 36.78% |
EBIT Margin | 34.33% |
FCF Margin | 6.36% |
Dividends & Yields
This stock pays an annual dividend of 0.41, which amounts to a dividend yield of 0.52%.
Dividend Per Share | 0.41 |
Dividend Yield | 0.52% |
Dividend Growth (YoY) | 92.49% |
Years of Dividend Growth | 5 |
Payout Ratio | 20.15% |
Buyback Yield | -0.56% |
Shareholder Yield | -0.03% |
Earnings Yield | 2.60% |
FCF Yield | 0.56% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |